Nuo Therapeutics, Inc. (AURX)

SG&A Expense Growth

3.12%

Quarterly · Period ending:

AURX logo

AURX SG&A Expense Growth

Latest reported3.12%
AURX Quarterly SG&A Growth (QoQ) (0.00% → 3.12%)
High-resolution chart · PNG

AURX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
3.1157%
2.247%
8.7678%
-2.2934%
7.6109%
18.2163%
10.6006%
0.7606%
-5.8005%
10.5825%
-16.5525%
-0.1165%
6.9801%
-11.576%
8.5676%
2.1537%
77.0207%
628.2672%
961.3539%
3.1317%
14.4206%
-98.2323%
5,074.8321%
0%
-246.1109%
-81.4435%
-39.6148%
-2.4123%
1.7556%
-2.0179%
4.2358%
-44.6944%
-3.3403%
-32.0509%
20.635%
-15.9634%
-1.2397%
-18.8053%
-20.5081%
-17.4079%
-24.817%
-17.9367%
-6.3567%
11.8139%
-1.4645%
-8.4797%
12.7232%
14.739%
-15.1998%
-6.6368%
-12.5283%
39.0361%
-6.6104%
0.0226%
-12.5343%
126.6625%
8.4099%
-5.4964%
-8.9627%
1.6713%
7.3845%
5.2252%
38.2375%
-0.8378%
35.8025%
-19.3141%
1.4107%
-13.0625%
8.8539%
-19.9162%
17.4059%
-6.4698%
-49.8694%
208.2668%
-17.6094%
1.9604%
-20.6452%
31.6498%
-24.9598%
25.2172%
-56.6606%
19.3834%
11.0528%
1.6504%
1.5783%
-9.3076%
-15.9328%
73.5786%
35.3565%
-7.4423%
60.9986%
-44.9579%
389.047%
24.9744%
14.9541%
-4.5806%
-62.4009%
-11.6506%
-10.3352%
-23.3188%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.